ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $610,023 | -9.9% | 38,318 | -7.4% | 0.03% | -27.5% |
| Q3 2022 | $677,000 | -66.9% | 41,394 | -71.5% | 0.04% | -71.0% |
| Q2 2022 | $2,047,000 | -41.8% | 145,289 | 0.0% | 0.14% | -20.2% |
| Q1 2022 | $3,519,000 | -32.9% | 145,289 | -35.4% | 0.17% | -28.8% |
| Q4 2021 | $5,248,000 | +52.4% | 224,830 | +8.5% | 0.24% | +53.8% |
| Q3 2021 | $3,443,000 | +15.9% | 207,284 | +70.2% | 0.16% | +19.7% |
| Q2 2021 | $2,971,000 | +32.2% | 121,802 | +39.8% | 0.13% | +33.3% |
| Q1 2021 | $2,247,000 | +5.5% | 87,111 | +118.7% | 0.10% | -18.9% |
| Q4 2020 | $2,129,000 | – | 39,823 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |